Drug Trial Radar · NCT05281484
Three Intermediate Expanded Access Protocols (EAP) CNMAu8.EAP01, CNMAu8.EAP02, and CNMAu8.EAP06 for ALS
Last checked: Nov 19, 2026Latest source record: Aug 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Available
Enrollment
Not stated
Start
Not stated
Primary completion
Not stated
Sponsor
- Lead sponsor
- Clene NanomedicineIndustry
- Sponsor type
- Industry
- First posted
- Mar 16, 2022
Design
- Study type
- Expanded access
- Who can join
- All sexes, from 18 years
Summary
As written by the sponsor on the registry.
The primary objective of the intermediate expanded access protocol is to provide access to the investigational product, CNM-Au8, to up to 300 people living with ALS (pALS). No formal clinical hypotheses are being evaluated with concurrent controls. Secondary objectives include assessment of the safety of CNM-Au8 treatment in pALS. Safety will be assessed through the frequency of serious adverse events (SAEs), treatment-emergent adverse events (TEAEs) assessed as 'severe', discontinuations due to TEAEs, and laboratory abnormalities assessed as clinically significant during routine clinical monitoring (as applicable).
Conditions
- Amyotrophic Lateral Sclerosis
Interventions
CNM-Au8Drug
CNM-Au8 is an aqueous suspension of clean surfaced faceted nanocrystals consisting of gold atoms self-organized into crystals of various geometrical shapes (hexagonal bi-pyramid, pentagonal bipyramid, tetrahedron, decahedron, planar spheroids). Highly pure elemental Au nanocrystals are suspended in USP purified deionized water buffered with 0.546 mg/mL (6.5 mM) sodium bicarbonate (NaHCO3) nominally concentrated to up to 0.5 mg/mL (500 ppm).
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Barrow Neurological Institute (Enrollment is full, not recruiting)
Phoenix, Arizona · Available
UC Irvine (Enrollment is full, not recruiting)
Orange, California · Available
Sutter Health (Enrollment is full, not recruiting)
San Francisco, California · Available
Hospital for Special Care (Enrollment is full, not recruiting)
New Britain, Connecticut · Available
Nova Southeastern University (Enrollment is full, not recruiting)
Davie, Florida · Available
Northwestern (Enrollment is full, not recruiting)
Chicago, Illinois · Available
University of Kansas (Enrollment is full, not recruiting)
Fairway, Kansas · Available
Massachusetts General Hospital (Enrollment is full, not recruiting)
Boston, Massachusetts · Available
Henry Ford Health Systems (Enrollment is full, not recruiting)
Detroit, Michigan · Available
University of Nebraska Medical Center (Enrollment is full, not recruiting)
Omaha, Nebraska · Available
DUKE University Medical Center
Durham, North Carolina · Available
Providence Health (Enrollment is full, not recruiting)
Portland, Oregon · Available
Penn State Health (Enrollment is full, not recruiting)
Hershey, Pennsylvania · Available
Jefferson Hospital (Enrollment is full, not recruiting)
Philadelphia, Pennsylvania · Available
Texas Neurology (Enrollment is full, not recruiting)
Dallas, Texas · Available
University of Washington (Enrollment is full, not recruiting)
Seattle, Washington · Available
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.